Navigation Links
Tremors connected to Body Mass Index

According to a new study from Columbia University researchers, people who suffer from the most common movement disorder, essential tremor (ET),// are more prone to have a lower body mass index than their healthy counterparts.

Essential tremor is a disorder of unknown origins, but doctors believe it may be neurodegenerative in nature. The condition causes increasingly severe tremors over time that can interfere with a person's daily activities, such as eating. It is generally worse in older individuals. Some people become so disabled by the disease they can no longer feed themselves independently.

Since other neurodegenerative disorders, such as Parkinson's disease and Alzheimer's, are associated with weight loss, these researchers decided to measure the BMI and caloric intake of patients with essential tremor and then compare them to those of people of similar ages without the condition. The study involved 70 ET patients and 200 healthy patients.

Although average caloric intake was similar for the two groups, the average BMI for the ET patients was 5 percent lower than in the healthy group. Average BMIs were 26.4 and 28.3, respectively and men were more affected than women. Researchers also found ET patients with lower BMIs suffered from more severe symptoms and longer tremor duration.

Researchers believe the lower BMIs seen in the ET patients could be the result of the greater amount of energy they expend during tremors. Since progressive weight loss, particularly in the elderly, is associated with an increased risk for hip fractures and death, they suggest physicians focus more attention on weight loss in ET patients.


'"/>




Page: 1

Related medicine news :

1. Botox Found To Be Effective for Voice Tremors
2. Sex exploitation connected to Schizophrenia
3. Diet, Sunlight connected to Breast Cancer Risk
4. Mutation connected to Osteoporosis
5. Tobacco and alcohol connected to larger health problems
6. Toxin connected to Flesh-eating Pneumonia in Kids
7. Leptin connected to obesity blood clots
8. Ulcer Surgery connected to danger of Pancreatic Cancer
9. Control of anger disorder connected to Brain Dysfunction
10. Altitude sickness connected to genes
11. Hyperflexible joints connected to chronic fatigue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Event in New York City, with long-time partners The Paul Foundation, on November ...
(Date:12/4/2016)... Aliso Viejo, California (PRWEB) , ... December 04, ... ... self-animating lower third presets that have new attractive animation styles with unique displacement ... Pro3rd Displace features 30 pre-animated lower third designs. Choose from a variety of ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... With ... struggling through rehabilitation of an injury, patients must find the one that works for ... his pain, he created a machine that worked and decided to share it with ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... EAST HANOVER, N.J. , Dec. 3, 2016 /PRNewswire/ ... SEG101 (crizanlizumab, formerly SelG1), an anti-P-selectin antibody, reduced the ... by 45.3% compared to placebo (1.63 vs 2.98, p=0.010) ... Novartis today announced that the data are being featured ... American Society of Hematology (ASH) Annual Meeting and ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: